The mobile stroke unit (MSU) refers to specially designed ambulance units that are equipped to provide acute stroke treatment on location. These units aim to minimize the time taken to treat stroke patients by bringing advanced diagnostics and thrombolysis capabilities to the patient's location. Mobile stroke units are staffed by neurologists, nurses, and paramedics trained in acute stroke care. They can perform CT scans, lab work, and administer clot-busting medications on-site to treat ischemic stroke patients within the golden hour post-stroke onset. This helps improve patient outcomes by potentially reversing neurological damage caused by impaired blood flow to the brain.
Market Dynamics:
The mobile stroke unit (MSU) market is driven by the growing incidence of stroke worldwide and the need to shorten the time taken to provide thrombolysis treatment. Approximately 6 million lives are lost to stroke each year, and numerous survivors grapple with disabilities, according to estimates. Reducing the time between stroke onset and treatment administration is critical to prevent permanent disability. Mobile stroke units facilitate faster treatment times by reaching patients 20-30 minutes before traditional emergency care. However, high setup and operational costs remain a key challenge for wider adoption of these specialized ambulances. Nonetheless, increasing research validating their clinical benefits is expanding payer coverage and offering new opportunities. Additionally, the incorporation of telestroke technologies allows remote specialist support, improving the feasibility of mobile stroke networks.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook